- Press releases - 18.01.2022
Cyclists and Pedestrians Inhale More Road Traffic Particles Than Motorized Transport Users
A team of scientists led by Inserm Research Director Basile Chaix at the Pierre Louis Institute of Epidemiology and Public Health (Inserm/Sorbonne Université) studied the impact of these parameters on exposure to black carbon, an air pollutant produced by road traffic.
- Press releases - 13.01.2022
Des mesures qui payent pour lutter contre la pollution atmosphérique
Reducing fine particle mortality in a conurbation by two-thirds could be achieved at a cost that is much lower than the value of the societal and economic benefits obtained, according to a study by a multidisciplinary team from CNRS, INSERM, INRAE, Grenoble Alpes University (UGA) and Atmo Auvergne-Rhône-Alpes. The study identifies specific public policies that could achieve health objectives set by local decision makers, as well as their expected co-benefits.
- Press releases - 11.01.2022
Identification d’une nouvelle cible thérapeutique du myélome multiple
Multiple myeloma is a cancer of the bone marrow, with a life expectancy of less than 5 years post-diagnosis. While studying a neglected tropical disease, Buruli ulcer, researchers from the Institut Pasteur and Inserm discovered a novel therapeutic target for multiple myeloma that could allow to bypass this resistance.
- Press releases - 05.01.2022
La consommation de cannabis dès l’adolescence serait associée à un risque plus élevé de chômage à l’âge adulte
France has one of the world’s highest levels of cannabis use, with around 40% of 17-year-olds reported to have used it in the previous year. New findings indicate that those having used cannabis are more likely to experience a period of unemployment later, especially if they were under 16 when they started.
- Press releases - 14.12.2021
A Common Food Additive Found to Alter the Human Microbiota and Intestinal Environment
Scientists had previously shown in mice that the presence of emulsifiers in many processed foods could promote intestinal inflammation. In a new study, the same team has shown in healthy human volunteers that carboxymethylcellulose (CMC), a widely used food emulsifier, affects the intestinal environment by altering the composition of the microbiota.
- Press releases - 10.12.2021
Does Falling Asleep Boost Creativity?
What if a few minutes of sleep could trigger creativity? This is what suggests a study by researchers from Inserm and Sorbonne Université at the Brain Institute and the department of sleep medicine at Pitié-Salpêtrière Hospital AP-HP.
- Press releases - 08.12.2021
COVID-19: New Avenues to Explain Why Children Are at Less Risk of Severe Forms
Why are children less susceptible than adults to critical forms of COVID-19? A number of interesting avenues are emerging, notably suggesting differences in immune response following SARS-CoV-2 infection. In a new study, researchers have shown that the interferon response, which is part of the innate immune response, differs according to the age of the patient.
- Press releases - 08.12.2021
Covid-19 booster doses: start of inclusions in the COVIBOOST trial
The French health authorities recommend that all adults over 18 years of age perform a booster injection with a MRNA to ensure maximum and prolonged vaccine protection. The COVIBOOST trial is designed to study the immune response of the two candidates based recombinant protein vaccine associated with an adjuvant developed by Sanofi Pasteur and GSK and that of a 3 rd dose of the Pfizer-Biontech vaccine.
- Press releases - 06.12.2021
Bronchopneumopathie chronique obstructive : une mutation génétique confirmée comme facteur de prédisposition
Des chercheurs ont montré que la substitution d’un seul nucléotide dans le gène qui code pour le récepteur nicotinique de l’acétylcholine peut entrainer des modifications fonctionnelles des cellules des voies aériennes et conduire à des symptômes similaires à ceux de la BPCO, indépendamment du tabagisme.
- Press releases - 02.12.2021
Inserm 2021 Prizes: Science More Mobilized Than Ever to Serve Health
In this year 2021, still marked by COVID-19, Inserm’s workers have remained mobilized to advance biomedical research and pursue their efforts across all areas of health research. To honor this collective endeavor, Inserm has awarded its 2021 Prizes to five people whose quality of work bears witness to the scientific excellence of the Institute’s research.